×
About 75,971 results

ALLMedicine™ Gastric Cancer Center

Research & Reviews  37,581 results

MicroRNA signatures associated with lymph node metastasis in intramucosal gastric cancer.
https://doi.org/10.1038/s41379-020-00681-x
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc; Kim S, Bae WJ et. al.

Sep 25th, 2020 - Although a certain proportion of intramucosal carcinomas (IMCs) of the stomach does metastasize, the majority of patients are currently treated with endoscopic resection without lymph node dissection, and this potentially veils any existing metast...

Deubiquitinase USP29 promotes gastric cancer cell migration by cooperating with phospha...
https://doi.org/10.1038/s41388-020-01471-0
Oncogene Qian W, Li Q et. al.

Sep 25th, 2020 - Snail is a master inducer of epithelial-mesenchymal transition (EMT) and metastasis, however, Snail protein is labile and is quickly degraded through the predominate ubiquitination-mediated proteasome pathway. Deubiquitinases (DUBs) can counteract...

Risk of Lymph Node Metastasis and Feasibility of Endoscopic Treatment in Ulcerative Ear...
https://doi.org/10.1245/s10434-020-09153-7
Annals of Surgical Oncology; Ren MH, Qi XS et. al.

Sep 25th, 2020 - When the risk of lymph node metastasis (LNM) is considered minimal in patients with early gastric cancer (EGC), endoscopic submucosal dissection (ESD) is an effective alternative to radical resection. This study aims to estimate the feasibility of...

Identification of hub genes and discovery of promising compounds in gastric cancer base...
https://doi.org/10.2217/bmm-2019-0608
Biomarkers in Medicine; Huang J, Wen F et. al.

Sep 24th, 2020 - Aim: To explore the mechanism of gastric carcinogenesis by mining potential hub genes and to search for promising small-molecular compounds for gastric cancer (GC). Materials & methods: The microarray datasets were downloaded from Gene Expression ...

Prognostic landscape of tumor-infiltrating immune cells and immune-related genes in the...
https://doi.org/10.18632/aging.103519
Aging Zhang S, Zeng Z et. al.

Sep 24th, 2020 - The tumor microenvironment is closely related to the progression and immune escape of tumor cells. Tumor-infiltrating immune cells (TIICs) and immune-related genes (IRGs) are indispensable components of the tumor microenvironment and have been dem...

see more →

Guidelines  83 results

Hereditary diffuse gastric cancer: updated clinical practice guidelines.
https://doi.org/10.1016/S1470-2045(20)30219-9
The Lancet. Oncology; Blair VR, McLeod M et. al.

Aug 7th, 2020 - Hereditary diffuse gastric cancer (HDGC) is an autosomal dominant cancer syndrome that is characterised by a high prevalence of diffuse gastric cancer and lobular breast cancer. It is largely caused by inactivating germline mutations in the tumour...

Enhertu Impresses in HER2-Positive Gastric Cancer
https://www.medpagetoday.com/meetingcoverage/asco/86766

May 28th, 2020 - Pretreated gastric cancer patients with HER2-positive disease had significantly improved rates of response and survival with trastuzumab deruxtecan (Enhertu) rather than chemotherapy, an open-label phase II trial showed.

Hereditary Cancer Syndromes and Risk Assessment ACOG COMMITTEE OPINION, Number 793
https://journals.lww.com/greenjournal/Fulltext/2019/12000/Hereditary_Cancer_Syndromes_and_Risk_Assessment_.39.aspx
Obstetrics & Gynecology; ACOG

Nov 30th, 2019 - A hereditary cancer syndrome is a genetic predisposition to certain types of cancer, often with onset at an early age, caused by inherited pathogenic variants in one or more genes. Most hereditary cancer syndromes exhibit autosomal dominant inheri...

Gastric Cancer Treatment (PDQ®)–Health Professional Version Go to Patient Version
https://www.cancer.gov/types/stomach/hp/stomach-treatment-pdq

Oct 10th, 2019 - Gastric cancer treatment options depend on extent of disease and may include radical surgery, chemotherapy, radiation, and immunotherapy. Get detailed information about the diagnosis, treatment, and prognosis of newly diagnosed and recurrent gastr...

Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial
https://www.bmj.com/content/366/bmj.l5016
The BMJ;

Sep 10th, 2019 - Objective To assess the effects of Helicobacter pylori treatment, vitamin supplementation, and garlic supplementation in the prevention of gastric cancer. Design Blinded randomized placebo controlled trial. Setting Linqu County, Shandong provinc...

see more →

Drugs  4 results see all →

Clinicaltrials.gov  37,943 results

MicroRNA signatures associated with lymph node metastasis in intramucosal gastric cancer.
https://doi.org/10.1038/s41379-020-00681-x
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc; Kim S, Bae WJ et. al.

Sep 25th, 2020 - Although a certain proportion of intramucosal carcinomas (IMCs) of the stomach does metastasize, the majority of patients are currently treated with endoscopic resection without lymph node dissection, and this potentially veils any existing metast...

Deubiquitinase USP29 promotes gastric cancer cell migration by cooperating with phospha...
https://doi.org/10.1038/s41388-020-01471-0
Oncogene Qian W, Li Q et. al.

Sep 25th, 2020 - Snail is a master inducer of epithelial-mesenchymal transition (EMT) and metastasis, however, Snail protein is labile and is quickly degraded through the predominate ubiquitination-mediated proteasome pathway. Deubiquitinases (DUBs) can counteract...

Risk of Lymph Node Metastasis and Feasibility of Endoscopic Treatment in Ulcerative Ear...
https://doi.org/10.1245/s10434-020-09153-7
Annals of Surgical Oncology; Ren MH, Qi XS et. al.

Sep 25th, 2020 - When the risk of lymph node metastasis (LNM) is considered minimal in patients with early gastric cancer (EGC), endoscopic submucosal dissection (ESD) is an effective alternative to radical resection. This study aims to estimate the feasibility of...

Identification of hub genes and discovery of promising compounds in gastric cancer base...
https://doi.org/10.2217/bmm-2019-0608
Biomarkers in Medicine; Huang J, Wen F et. al.

Sep 24th, 2020 - Aim: To explore the mechanism of gastric carcinogenesis by mining potential hub genes and to search for promising small-molecular compounds for gastric cancer (GC). Materials & methods: The microarray datasets were downloaded from Gene Expression ...

Prognostic landscape of tumor-infiltrating immune cells and immune-related genes in the...
https://doi.org/10.18632/aging.103519
Aging Zhang S, Zeng Z et. al.

Sep 24th, 2020 - The tumor microenvironment is closely related to the progression and immune escape of tumor cells. Tumor-infiltrating immune cells (TIICs) and immune-related genes (IRGs) are indispensable components of the tumor microenvironment and have been dem...

see more →

News  355 results

Enhertu Impresses in HER2-Positive Gastric Cancer
https://www.medpagetoday.com/meetingcoverage/asco/86766

May 28th, 2020 - Pretreated gastric cancer patients with HER2-positive disease had significantly improved rates of response and survival with trastuzumab deruxtecan (Enhertu) rather than chemotherapy, an open-label phase II trial showed.

Study eyes gastric cancer predictors in Lynch syndrome
https://www.mdedge.com/gihepnews/article/218873/gastroenterology/study-eyes-gastric-cancer-predictors-lynch-syndrome?channel=69
Amy Karon, MDedge News

Mar 12th, 2020 - Individuals with Lynch syndrome were significantly more likely to have a personal history of gastric cancer if they were older, male, had an affected first-degree relative, or had pathogenic variants in the MLH1 or MSH2 mismatch repair genes, rese.

Best definition of malnutrition varies by cancer type
https://www.mdedge.com/fedprac/article/218579/patient-survivor-care/best-definition-malnutrition-varies-cancer-type/page/0/1?channel=27442

Mar 6th, 2020 - Interpreting and applying the results “The biggest takeaway is that the optimal definition of malnutrition varies by cancer type,” Dr. McKenna said in an interview.

Avelumab maintenance in gastric cancer is down but maybe not out
https://www.mdedge.com/emergencymedicine/article/216610/gastroenterology/avelumab-maintenance-gastric-cancer-down-maybe-not/page/0/1?channel=53

Feb 3rd, 2020 - A ‘yin-yang’ pattern of survival “Monotherapy checkpoint blockade with anti–programmed death-1 (PD-1) and anti–PD-L1 inhibitors has had relatively unimpressive results in gastroesophageal adenocarcinoma as a whole,” said invited discussant Daniel.

Hope springs eternal
https://www.mdedge.com/gihepnews/article/216148/mixed-topics/hope-springs-eternal?channel=52

Feb 1st, 2020 - As practicing clinicians, we all want to do what is best for patients. We hope our treatments will improve actual health outcomes (and not intermediate process metrics), so we make decisions based on “evidence” that lies on a continuum from “I hop.

see more →

Patient Education  5 results see all →